EA200601410A1 - Новая комбинация агомелатина и ингибитора обратного поглощения норадреналина и фармацевтические композиции, которые её содержат - Google Patents

Новая комбинация агомелатина и ингибитора обратного поглощения норадреналина и фармацевтические композиции, которые её содержат

Info

Publication number
EA200601410A1
EA200601410A1 EA200601410A EA200601410A EA200601410A1 EA 200601410 A1 EA200601410 A1 EA 200601410A1 EA 200601410 A EA200601410 A EA 200601410A EA 200601410 A EA200601410 A EA 200601410A EA 200601410 A1 EA200601410 A1 EA 200601410A1
Authority
EA
Eurasian Patent Office
Prior art keywords
agomelatin
noradrenaline
pharmaceutical compositions
new combination
absorption inhibitor
Prior art date
Application number
EA200601410A
Other languages
English (en)
Other versions
EA011650B1 (ru
Inventor
Элизабет Мока
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA200601410A1 publication Critical patent/EA200601410A1/ru
Publication of EA011650B1 publication Critical patent/EA011650B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Комбинация, содержащая агомелатин, или N-[2-(7-метокси-1-нафтил)этил]ацетамид, в сочетании со средством, ингибирующим обратное поглощение норадреналина.
EA200601410A 2005-09-09 2006-08-31 Комбинация агомелатина и ингибитора обратного захвата норадреналина и фармацевтические композиции, которые её содержат EA011650B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0509206A FR2890564B1 (fr) 2005-09-09 2005-09-09 Nouvelle association entre l'agomelatine et un inhibiteur de la recapture de la noradrenaline et les compositions pharmaceutiques qui la contiennent

Publications (2)

Publication Number Publication Date
EA200601410A1 true EA200601410A1 (ru) 2007-04-27
EA011650B1 EA011650B1 (ru) 2009-04-28

Family

ID=36190808

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601410A EA011650B1 (ru) 2005-09-09 2006-08-31 Комбинация агомелатина и ингибитора обратного захвата норадреналина и фармацевтические композиции, которые её содержат

Country Status (39)

Country Link
US (1) US7622505B2 (ru)
EP (1) EP1769798B1 (ru)
JP (2) JP5395998B2 (ru)
KR (1) KR100863384B1 (ru)
CN (1) CN1927205A (ru)
AP (1) AP2615A (ru)
AR (1) AR056056A1 (ru)
AT (1) ATE404205T1 (ru)
AU (1) AU2006209368B2 (ru)
BR (1) BRPI0603759A (ru)
CA (1) CA2558782C (ru)
CY (1) CY1108319T1 (ru)
DE (1) DE602006002210D1 (ru)
DK (1) DK1769798T3 (ru)
EA (1) EA011650B1 (ru)
ES (1) ES2313590T3 (ru)
FR (1) FR2890564B1 (ru)
GE (1) GEP20094742B (ru)
GT (1) GT200600408A (ru)
HR (1) HRP20080535T3 (ru)
JO (1) JO2521B1 (ru)
MA (1) MA28505B1 (ru)
ME (2) ME02767B (ru)
MX (1) MXPA06010157A (ru)
MY (1) MY142260A (ru)
NO (1) NO338029B1 (ru)
NZ (1) NZ549725A (ru)
PE (1) PE20070429A1 (ru)
PL (1) PL1769798T3 (ru)
PT (1) PT1769798E (ru)
RS (1) RS50631B (ru)
SA (1) SA06270308B1 (ru)
SG (1) SG131030A1 (ru)
SI (1) SI1769798T1 (ru)
TW (1) TWI324513B (ru)
UA (1) UA83542C2 (ru)
UY (1) UY29778A1 (ru)
WO (1) WO2007028904A1 (ru)
ZA (1) ZA200607562B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4642134B2 (ja) * 2007-05-01 2011-03-02 コンサート ファーマシューティカルズ インコーポレイテッド ナフチル（エチル）アセトアミド
WO2008141033A1 (en) * 2007-05-08 2008-11-20 Auspex Pharmaceuticals Inc. Substituted naphthalenes
CN102342924A (zh) * 2010-08-05 2012-02-08 北京本草天源药物研究院 一种含有阿戈美拉汀的药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843071A (en) * 1986-12-05 1989-06-27 Serotonin Industries Of Charleston Method and composition for treating obesity, drug abuse, and narcolepsy
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ZA985765B (en) * 1997-07-02 1999-08-04 Merck & Co Inc Polymorphic form of a tachykinin receptor antagonist.
ZA989251B (en) * 1997-10-17 2000-04-10 Lilly Co Eli Potentiation of pharmaceuticals.
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
JP2005518439A (ja) * 2002-02-26 2005-06-23 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 抗痙攣性誘導体と抗片頭痛薬を含んで成る片頭痛治療用共治療薬
JP2004292445A (ja) * 2003-03-11 2004-10-21 Katsunori Nonogaki 糖尿病治療薬
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
BRPI0414347A (pt) * 2003-09-12 2006-11-07 Warner Lambert Co associação compreendendo um ligando de alfa-2-delta e um ssri e/ou snri para tratamento de depressão e distúrbios da ansiedade

Also Published As

Publication number Publication date
AR056056A1 (es) 2007-09-12
CA2558782C (fr) 2012-05-15
GEP20094742B (en) 2009-07-27
NZ549725A (en) 2008-03-28
UY29778A1 (es) 2006-10-31
CA2558782A1 (fr) 2007-03-09
CN1927205A (zh) 2007-03-14
NO338029B1 (no) 2016-07-25
KR100863384B1 (ko) 2008-10-13
ME02758B (me) 2010-06-30
RS50631B (sr) 2010-06-30
JO2521B1 (en) 2010-03-17
ATE404205T1 (de) 2008-08-15
TWI324513B (en) 2010-05-11
SI1769798T1 (sl) 2008-12-31
ME02767B (me) 2010-06-30
MY142260A (en) 2010-11-15
PL1769798T3 (pl) 2008-12-31
NO20064048L (no) 2007-03-12
AP2615A (en) 2013-03-14
WO2007028904A1 (fr) 2007-03-15
MXPA06010157A (es) 2007-03-08
ZA200607562B (en) 2008-05-28
AU2006209368B2 (en) 2012-07-19
EA011650B1 (ru) 2009-04-28
BRPI0603759A (pt) 2007-05-15
FR2890564A1 (fr) 2007-03-16
US20070060654A1 (en) 2007-03-15
CY1108319T1 (el) 2014-02-12
AP2008004378A0 (en) 2008-04-30
DE602006002210D1 (de) 2008-09-25
AU2006209368A1 (en) 2007-03-29
JP2007077147A (ja) 2007-03-29
JP5395998B2 (ja) 2014-01-22
TW200744570A (en) 2007-12-16
EP1769798B1 (fr) 2008-08-13
FR2890564B1 (fr) 2007-10-19
ES2313590T3 (es) 2009-03-01
KR20070029606A (ko) 2007-03-14
PE20070429A1 (es) 2007-06-02
PT1769798E (pt) 2008-09-18
MA28505B1 (fr) 2007-04-03
SG131030A1 (en) 2007-04-26
EP1769798A1 (fr) 2007-04-04
JP2011088919A (ja) 2011-05-06
UA83542C2 (ru) 2008-07-25
US7622505B2 (en) 2009-11-24
GT200600408A (es) 2007-05-21
HRP20080535T3 (en) 2008-12-31
DK1769798T3 (da) 2008-11-24
SA06270308B1 (ar) 2011-10-08

Similar Documents

Publication Publication Date Title
IL196462A (en) (s) - n - (3 - chloro - 4 - cyanophenyl) - 3 - (4 - cyanophenoxy) - 2 - hydroxy - 2 - methylpropanamide, composition and use
AR058753A1 (es) Uso de composiciones nutricionales con fosfolipidos esfingolipidos y colesterol
EA200701790A1 (ru) Твёрдый фармацевтический дозированный состав
DOP2013000169A (es) Compuesto para uso en el tratamiento de la artritis
EA200601449A1 (ru) Применение агомелатина для получения лекарственных средств, предназначенных для лечения нарушений сна у пациента с депрессией
CY1118976T1 (el) Κρυσταλλικες τροποποιησεις της (1r,2r)-3-(3-διμεθυλαμινο-1-αιθυλ-2-μεθυλ-προπυλ)-φαινολης
AR047553A1 (es) La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
EA200601410A1 (ru) Новая комбинация агомелатина и ингибитора обратного поглощения норадреналина и фармацевтические композиции, которые её содержат
RS51534B (en) NEW COMPOUND OF SINUSOID IF CURRENT INHIBITORS AND CALCIUM INHIBITOR AND PHARMACEUTICAL MIXTURE CONTAINED BY IT
EA200801875A1 (ru) Антагонист cd 80
CL2007003396A1 (es) Uso de agomelatina o n-[2-(7-metoxi-1-naftil)etil]acetamida para el tratamiento del sindrome de smith magenis; composicion farmaceutica que contiene agomelatina.
AR057277A1 (es) Utilizacion de agomelatina para la obtencion de medicamentos destinados al tratamiento de los trastornos bipolares
EA200601450A1 (ru) Новая комбинация агомелатина и тиморегулирующего средства и фармацевтические композиции, которые её содержат
JO2631B1 (en) Use agomelatine to obtain medications to treat leukoplakia around the brain ventricles
AR047550A1 (es) Tratamiento de la depresion y otros trastornos afectivos
TW200744571A (en) Combination of β3 receptor agonist and of monoamine reuptake inhibitors, pharmaceutical composition containing it and therapeutic use thereof
RU2006134113A (ru) Применение атипичного нейролептика эглонила и антидепрессанта-селективного ингибитора обратного захвата серотонина триттико при лечении экземы
TH103346A (th) อนุพันธ์ของ n-[(1,5-ไดเฟนิล-1h-พิราซอล-3-อิล)เมทิล]ซัลโฟนามีด การเตรียม และการใช้สารนั้นรักษาโรค
RU2006134807A (ru) Применение "дневного" транквилизатора фенибута и антидепрессанта - селективного ингибитора обратного захвата серотонина триттико при лечении псориаза
TH87501B (th) ความเกี่ยวข้องใหม่ระหว่างอะโกเมลาทีน และตัวยับยั้งการดูดซึมกลับใหม่ของเนอร์อะดรีนาลีน, และสารผสมทางเภสัชกรรมที่มีสิ่งนี้

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU